Journal of Applied Physiology AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 89: 153-162, 2000;
8750-7587/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nattie, E.
Right arrow Articles by Li, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nattie, E.
Right arrow Articles by Li, A.
Vol. 89, Issue 1, 153-162, July 2000

Muscimol dialysis in the retrotrapezoid nucleus region inhibits breathing in the awake rat

Eugene Nattie and Aihua Li

Department of Physiology, Dartmouth Medical School, Lebanon, New Hampshire 03756-0001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Under anesthesia, inactivation of the retrotrapezoid nucleus (RTN) region markedly inhibits breathing and chemoreception. In conscious rats, we dialyzed muscimol for 30 min to inhibit neurons of the RTN region reversibly. Dialysis of artificial cerebrospinal fluid had no effect. Muscimol (1 or 10 mM) significantly decreased tidal volume (VT) (by 16-17%) within 15 min. VT remained decreased for 50 min or more, with recovery by 90 min. Ventilation (VE) decreased significantly (by 15-20%) within 15 min and then returned to baseline within 40 min as a result of an increase in frequency. This, we suggest, is a compensatory physiological response to the reduced VT. Oxygen consumption was unchanged. In response to 7% CO2 in the 1 mM group, absolute VE and change in VE were significantly reduced (by 19-22%). In the 10 mM group, the response to dialysis included a time-related increase in frequency and decrease in body temperature, which may reflect greater spread of muscimol. In the awake rat, the RTN region provides a portion of the tonic drive to breathe, as well as a portion of the response to hypercapnia.

control of breathing; GABAA receptors; rostral ventrolateral medulla; central chemoreceptors; hypoventilation


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

THE ROSTRAL VENTROLATERAL MEDULLA (RVLM) contains neurons involved in the control of breathing. Acidic stimulation of the medullary surface at the RVLM increased respiratory output (see Refs. 4, 17, 18), and surface cooling there produced apnea and a severely curtailed CO2 sensitivity in anesthetized animals (4). Focal cooling by a small probe (5) showed the most sensitive site to include the retrotrapezoid nucleus (RTN), parapyramidal neurons of the medullary raphe, and juxtafacial portions of the nucleus paragigantocellularis lateralis (PGCL). The neurons of the RTN, as described by retrograde tracing experiments (26), lie ventral to the facial nucleus, extending for a small distance rostral and caudal to this structure. Our operative definition of the RTN region includes the RTN proper together with adjacent parapyramidal neurons and neurons within the juxtafacial PGCL.

In anesthetized cats and rats, focal acidification in the RTN region stimulated respiratory output (6, 15, 16), whereas focal destruction by neurotoxin injection (17-19, 21) substantially reduced phrenic nerve activity and the response to systemic hypercapnia. The importance of these two functions of the RTN region in more physiological conditions, i.e., in the absence of anesthesia, is less certain. This paper represents the second in a series of studies from our lab designed to test the hypothesis that neurons in the RTN region provide a tonic drive to breathe and are an integral part of the central chemoreceptor system in the conscious mammal. In the first study, we produced unilateral and focal destruction of a portion of the RTN region by neurotoxin, injected under anesthesia, in the rat (1). After 2 days of recovery, the rats were studied in the waking state over 3 wk. These animals, with histologically proven RTN lesions, breathed normally at rest but had a 39% reduction in the response to systemic hypercapnia, a substantial effect but less dramatic than that observed under anesthesia.

Other investigators have studied the role of neurons in the RVLM in awake mammals. Bilateral lesions produced by electrocoagulation in the cat RVLM, in an area that included the RTN region, resulted in hypoventilation during wakefulness and a markedly diminished response to hypercapnia (25). In the unanesthetized goat (10, 21), focal cooling of the RVLM, including the RTN region, decreased ventilation (VE) and the response to hypercapnia in the waking state, but the effects were small compared with those observed with cooling of the same location under anesthesia. In both studies, the size of the region affected was likely to be substantially larger than in our rat neurotoxin study.

The purpose of this study is to evaluate the role of neurons in the RTN region in the control of breathing in the awake state by focally, acutely, and reversibly altering their function. The model is an unanesthetized rat with the GABAA receptor agonist muscimol applied to the RTN region by microdialysis. Our rationale is that the use of muscimol to inhibit RTN neurons in the awake rat may allow us to uncover their function by avoiding less specific and more widespread effects produced by neuronal destruction or cooling. The hypothesis is that the RTN provides a tonic stimulation of breathing in wakefulness and the full ventilatory response to systemic hypercapnia requires the integrity of the RTN.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Sprague-Dawley rats weighing 300-400 g were anesthetized with intramuscular ketamine (100 mg/kg) and intraperitoneal xylazine (20 mg/kg). With the rat in a Kopf stereotaxic device, a guide tube of 0.38 mm outside diameter filled with a dummy cannula (CMA/11, Acton, MA) was inserted 10.6-10.8 mm below the dorsal surface of the skull at coordinates 2.2 mm caudal to lambda and 1.8 mm lateral from the midline (24). The guide tube was secured to the skull with cranioplastic cement, and the wound was sutured. A sterile telemetric temperature probe (TA-F20, Data Sciences, St. Paul, MN) was placed unattached in the abdominal cavity. The animal was allowed to recover for 3-4 days. In four rats, an arterial catheter was implanted into the femoral artery and threaded subcutaneously, exiting at the back of the neck. It was connected via saline-filled tubing to a transducer for measurement of blood pressure.

On each experimental day, the rat was weighed, the dummy cannula was removed, and the dialysis probe was inserted into the guide tube. The active dialysis site, which protruded 1 mm beyond the guide tube tip, was 1 mm in length and 0.24 mm in diameter, with membrane pores limiting movement to molecules under 6,000 Da. Animals were placed into a Pappenheimer-style plethysmograph chamber (7, 23) and allowed 30-40 min to acclimate. We measured VE, oxygen consumption (VO2), and body temperature (Tb). After acclimation, three sets of data while the animals were breathing room air and one during an initial CO2 response were obtained over 50 min with the dialysis probe in place but without flow through it. The dialysis pump was then turned on with artificial cerebrospinal fluid (aCSF) flowing at a rate of 4.0 µl/min. The composition of the aCSF was (in mM) 152 sodium, 3.0 potassium, 2.1 magnesium, 2.2 calcium, 131 chloride, and 26 bicarbonate. The calcium was added after the aCSF was warmed to 37°C and equilibrated with 5% CO2. Air-breathing measurements were repeated over 10 min, and then the dialysate was switched to 1) aCSF, 2) 1 mM muscimol in aCSF, or 3) 10 mM muscimol in aCSF. The time at which the new dialysate reached the tissue (washout of the dead space accounted for) is determined as t = 0 in our analysis. After 30 min, the dialysate was changed to aCSF, which was continued for the final 60 min. Measurements were taken over a 20- to 30-s period at 0, 5, 15, 40, 50, 60, and 90 min. We collected data for up to 190 min, but we focused our formal statistical analysis and report on only the results to 90 min. The reason for this is an unexpected and large decrease in Tb observed in the 10 mM muscimol group beginning at 90 min. The entire experimental period was 2.5 h.

We added fast green dye to the dialysate to facilitate visualization of the dialysate outflow and to allow a histological test for membrane leak. In addition, we examined the membrane just after each dialysis. We monitored the outflow rate semiquantitatively by visualization of the drops of dialysate coming out of the outflow tubing. Animals in this report did not have leaks in the dialysis membrane during the experiment.

There were three experimental groups. Group 1 (n = 7 trials in 6 rats) was dialyzed during the 30-min treatment period with aCSF used as the vehicle. Group 2 (n = 6 trials in 5 rats) was dialyzed with 1 mM muscimol in aCSF and Group 3 (n = 5 trials in 4 rats) with 10 mM muscimol. Eight animals were used overall. One received all three treatments, one received one treatment, and all others received two of the three treatments. The rats were studied in a state that we refer to as quiet wakefulness. The experiments were performed between 9 AM and 4 PM. The rats were housed on a midnight-to-noon circadian light-dark cycle, so we collected data during the end of the quiet/sleep (light) circadian period and the beginning of the active/wake (dark) circadian period. This yielded reproducible data representing quiet wakefulness. If we waited until later in the active/wake period, the rats were more prone to sniffing, grooming, and active movement such that the ventilatory data were more variable and difficult to obtain. The rats were under constant observation during the experiment and were studied in subdued light.

For the CO2 response, the inspired CO2 was increased by switching the inflow gas to a mixture with 7% CO2 and 93% air, which slowly increased the inspired CO2 value over 8-9 min, as measured in the outflow gas. We measured ventilatory variables from 8 to 9 and from 9 to 10 min, as shown in Figs. 2-4. These values were essentially the same at the two measurement periods. CO2 responses were measured before, during, and just after dialysis treatment to evaluate the effects of muscimol on the response to increased CO2.

The plethysmograph chamber used in these experiments is similar to that described by Pappenheimer (23). The analog output of the pressure transducer was recorded on a strip chart recorder (Honeywell, model 1200) and Vetter Digital system (model 3000A). Inflow of humidified gas and outflow are balanced by using a flowmeter (Matheson, model 7491T) and a vacuum system. The flow rate through the plethysmograph was at or above 1.4 l/min, with 100 ml/min of outflow gas going to the O2 and CO2 analyzer (Applied Electrochemistry, model SA-3). The temperature in the chamber was measured before each measurement period. Rat Tb was measured continuously via the analog output from the telemetric temperature probe in the abdomen. The plethysmograph chamber was calibrated each day with 0.3 ml of air injected at approximately the rate of inspiration. Calibrations are performed with the rat replaced by an equally sized inert object, which allows a more accurate and reliable calibration, and with the rat in the chamber, which evaluates the chamber leak rate.

Analog respiratory data were digitized (DataPac III), and a breath-by-breath analysis was performed with the pressure deflections and the respiratory cycle time for each breath determined over a 20- to 30-s time period (DataPac III). VT (per 100 g of body wt), f, and VE (per 100 g body wt) were calculated (SigmaPlot IV). VO2 was determined by the difference in outflow oxygen (determined by the O2 sensor) vs. inflow oxygen with a constant flow rate of 1.4 µl/min.

The results for VE, VT, f, VO2, and Tb in room air or breathing 7% CO2 were compared within each experimental group by one-way repeated-measures ANOVA and among the experimental groups by a two-way ANOVA with treatment (aCSF, 1 mM muscimol, 10 mM muscimol) and time as factors (Sigmastat, Jandel Scientific software; SYSTAT). In some cases, the Friedman repeated-measures ANOVA on ranks was required. Post hoc tests (Dunnett's; Student-Newman-Keuls) were performed when significant differences were found. The air-breathing ventilatory data were evaluated in two ways. First, the absolute values of VE, VT, and f in the 12 air-breathing measurement periods were compared over the entire 2.5-h experiment. Second, these data are expressed as percent of baseline (%baseline), which was determined as the mean of three sets of measurements made over 10 min before the onset of dialysis. This was done because we were unable to use the same animals reliably for all three dialysis tests and we wanted to normalize for differences in initial values among the groups.

The CO2 breathing data are evaluated in two ways. First, the absolute values of VE, VT, and f are compared (one-way ANOVA) for the three CO2 tests before, during, and after each dialysis treatment (aCSF, 1 mM, 10 mM muscimol). Second, the change in these values, calculated as the CO2-stimulated value at each CO2 challenge minus the average of the control values just before and after, are compared for the three CO2 tests before, during, and after dialysis treatment (one-way ANOVA). After the last 7% CO2 reading, the inspired gas is switched to air, and the plethysmograph is opened briefly to allow the high CO2 to escape. On closure of the plethysmograph, another ~10 min are allowed to pass before the initial post-CO2 stimulation values are taken.

At the conclusion of the experiments, the animals were killed, and the medulla was removed and placed in 4% paraformaldehyde. They were frozen then sectioned at 50-µm thickness with a Reichert-Jung cryostat. Sections were counterstained with cresyl violet, and with the assistance of a rat brain atlas, we identified anatomical landmarks and the site of dialysis probe placement (24). The guide tubes were removed postmortem but before brain stem removal and sectioning. To remove them required manipulation and produced tissue disruption. This facilitated the anatomical verification of guide tube and probe tip location but also increased the volume of tissue disruption compared with that produced by simple insertion. In two additional rats, a 30-min period of dialysis with a fluorescein dye of molecular weight (332) similar to that of muscimol (195) was followed by a 15-min dialysis of aCSF before death. The brain stems of these animals were frozen immediately, sectioned, and viewed with a fluorescence microscope, with the appropriate images digitized via camera and computer. This approach, used in an earlier paper (7), allowed an approximate evaluation of the spread of the muscimol into the brain stem during dialysis.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Figure 1 shows digitized tracings of plethysmograph pressure for representative sections of breathing during a typical experiment with 1 mM muscimol in the test-period dialysate. Note that VT is decreased after muscimol exposure in the RTN region while the animal is breathing air or increased CO2.


View larger version (35K):
[in this window]
[in a new window]
  		Fig. 1.   Digitized plethysmograph tracings from one experiment. Right: records obtained during the 7% CO2 test. Left: records obtained during air breathing in the quiet wakeful state. Each record represents data from a different time period in the protocol. B1 and B2, baseline data periods before and after the initial CO2 test. 15, 60, and 90 min, Data obtained at those time periods after the onset of 30-min test dialysis, here 1 mM muscimol. The second and third CO2 tests show data obtained during and just after the 30-min muscimol dialysis.

The mean ± SE absolute values of VE, VT, and f over the entire 2.5-h experiment are shown in Figs. 2-4 for dialysis with aCSF and 1 mM or 10 mM muscimol, respectively. These same data are expressed as %baseline in Fig. 5.


View larger version (14K):
[in this window]
[in a new window]
  		Fig. 2.   Mean ± SE absolute values for ventilation (VE), tidal volume (VT), and respiratory frequency (f) as a function of time during the 2.5-h duration of the experiment with dialysis of artificial cerebrospinal fluid (aCSF) only into the retrotrapezoid nucleus (RTN) (n = 7 trials in 6 rats). For the initial 90 min, the dialysis probe is in place, filled with aCSF, but there is no flow. At ~10 min before the onset of the experiment, flow is turned on through the dialysis probe. When the new dialysate reaches the tissue (t = 0), the solution here is maintained as aCSF. In the other groups, 1 or 10 mM muscimol dialysis is begun. After 30 min of dialysis, a 60-min period of washout begins, which, in this group, consists of continued dialysis with aCSF. Before, during, and after the 30-min test dialysis period, three CO2 responses are measured. The CO2 content of the chamber is quickly increased to 7% and ventilatory measurements (shown above values measured for animals breathing room air in each chart) are made from 8 to 9 and 9 to 10 min. Values are means ± SE.



View larger version (14K):
[in this window]
[in a new window]
  		Fig. 3.   Results from RTN dialysis with 1 mM muscimol (n = 6 trials in 5 rats) during the 30-min dialysis test period. See legend to Fig. 2 for details.



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 4.   Results from RTN dialysis with 10 mM muscimol (n = 5 trials in 4 rats) during the 30-min dialysis test period. See legend to Fig. 2 for details.



View larger version (16K):
[in this window]
[in a new window]
  		Fig. 5.   Mean ± SE values for VE, VT, and f, expressed as percent of initial baseline, for three dialysis groups: aCSF (triangle ); 1 mM muscimol (); and 10 mM muscimol (open circle ). Period of test dialysis is shown by the solid horizontal line. Washout with aCSF continued until 90 min. For VE, comparing data among all three groups, there was a significant difference between the aCSF and the 1 mM muscimol results (P < 0.05). Among just the 1 mM results, there was a significant difference at 5 and 15 min (P < 0.05). For VT, among all three groups, both the 1 mM and the 10 mM groups differed from the aCSF group (P < 0.003). Within the 1 mM group, VT was significantly decreased at 15 and 50 min; within the 10 mM group, it was significantly decreased at 5, 15, 40, 50, 60, and 90 min. For f, comparing data among all three groups, there was a significant difference between the aCSF and the 10 mM muscimol results. Among just the 10 mM results, f was significantly increased. (See text for details.)

Unilateral RTN dialysis with aCSF: Effects on VE. There was remarkably little change in VE, VT, and f over the 2.5-h experiment, including the period of no dialysis during the first 50 min and the period of aCSF dialysis over the next 100 min (Fig. 2). One-way repeated-measures ANOVA showed no significant changes in VE, f, or VT. When analyzed as %baseline (Fig. 5), none of the three ventilatory variables showed any significant change over the 30-min aCSF test dialysis and the 60-min aCSF dialysis recovery period.

Unilateral RTN dialysis with 1 mM and 10 mM muscimol: Effects on VE. Absolute VE analyzed for all data over the 2.5-h experiment was significantly lower in the 1-mM treatment group compared with the aCSF group (Figs. 2-4; two-way ANOVA; F = 15.976; df = 2; P < 0.001; Dunnett's post hoc comparison; P < 0.05 for aCSF vs. 1 mM muscimol; there was no effect of time or treatment × time). The absolute values of VT or f for all data did not differ among the groups because the initial absolute values of these variables differed.

Analysis of absolute values within groups did show significant effects. One-way repeated-measures ANOVA for the 1-mM muscimol treatment group showed a significant decrease in VT (F = 2.318; df = 11; P = 0.02) and VE (F = 2.369; df = 11; P = 0.018) with no effect on f. One-way repeated-measures ANOVA for the 10-mM muscimol treatment group showed a significant decrease in VT (F = 5.745; df = 11; P < 0.001), no effect on VE, and a significant increase in f (Friedman repeated-measures ANOVA on ranks; chi 2 = 23.087; df = 11; P = 0.017). Post hoc analysis to pinpoint the exact times at which these effects were significant within each group suffered from the variability of absolute values within treatment groups.

Given the variability of the initial absolute VT and f values, we repeated the analyses using the data expressed as %baseline as shown in Fig. 5. Baseline was defined as the average of the three sets of data obtained just before t = 0, the onset of dialysis treatment. Both doses of muscimol produced significant effects on VT. Two-way ANOVA of the data in all three groups over the time period of the experiment showed a significant effect for treatment (F = 6.824; df = 2; P = 0.002), with post hoc analysis showing significance of the 1 mM and 10 mM results compared with aCSF (Student-Newman-Keuls test; P < 0.05). There was no effect of time nor was there an interactive effect. One-way repeated-measures ANOVA within the 1 mM group showed a significant effect (F = 2.445; df = 6; P = 0.048) at 15 and 50 min (Dunnett's test; P < 0.05), with mean ± SE values that were 86 ± 4 and 83 ± 7% of baseline, respectively. Friedman repeated-measures ANOVA within the 10 mM group showed a significant effect (chi 2 = 18.343; df = 6; P = 0.005) at 5, 15, 40, 50, 60, and 90 min (Dunnett's test; P < 0.05), with respective median values, expressed as %baseline, of 93, 84, 75, 78, 79, and 91. Recovery from the 30-min test dialysis took place by 60-90 min in the 1 mM group and was approaching completion at 90 min in the 10 mM group. Unilateral muscimol dialysis into the RTN region decreased VT in the awake rat.

The effects on f were somewhat different. Two-way ANOVA, constructed as for the VT analysis above, showed a significant effect for treatment (F = 6.674; df = 2; P = 0.002) and for time (F = 2.493; df = 6; P = 0.027) with no interactive effect. However, post hoc evaluation showed this to be significant for the comparison between aCSF and the 10 mM dose (P < 0.05; Dunnett's test). Repeated-measures one-way ANOVA of the data in the 1-mM group showed no significant effect. In the 10 mM dose group, f was increased significantly (F = 2.559; df = 6; P = 0.046). Muscimol dialysis into the RTN region produced an increase in f that was noted just after the cessation of dialysis and likely began during the dialysis and that reached significance in the 10 mM group.

VE decreased initially during dialysis with both the 1 mM and 10 mM doses to values of 81.9 ± 7 and 79.7 ± 7% of baseline, respectively, at 5 min and to values of 84.8 ± 2 and 83.2 ± 7% of baseline, respectively, at 15 min. Two-way ANOVA of the %baseline data evaluating the effects of treatment and time shows a significant effect of 1 mM treatment vs. aCSF (F = 3.229; df = 2; P = 0.044) at 5 and 15 min (Dunnett's test; P < 0.05). One-way repeated-measures ANOVA on the 1 mM results shows a significant effect (F = 3.204; df = 6; P = 0.015) at 5 and 15 min (Dunnett's test; P < 0.05). One way repeated-measures ANOVA on 10 mM results showed a significant effect (F = 3.960; df = 6; P = 0.007), but post hoc analysis shows this to be the value at 90 min vs. all other values (P < 0.05; Student-Newman-Keuls).

Dialysis with 1 mM and 10 mM muscimol: Effects on VO2, Tb, and blood pressure. Dialysis with the 1 mM or 10 mM dose of muscimol had no significant effect on VO2 (Fig. 6). The 1 mM and 10 mM doses had significant effects on Tb (one-way repeated-measures ANOVA; P < 0.005) at 60 and 90 min for each dose (Dunnett's test; P < 0.05). In the 10 mM dose group, Tb continued to decrease after 90 min to values of 36°C at 180 min (data not shown). Mean arterial blood pressure was unaffected by the 1 mM dose (Fig. 6; four trials in three rats). Blood pressure measured in a single animal dialyzed with 10 mM muscimol was unaffected.


View larger version (15K):
[in this window]
[in a new window]
  		Fig. 6.   Mean ± SE values for oxygen consumption (VO2) and body temperature (Tb) for the three dialysis groups: aCSF (triangle ); 1 mM muscimol (); 10 mM muscimol (open circle ). Period of dialysis is shown by the solid horizontal line. Washout with aCSF continued until 90 min. Bottom: mean ± SE values for mean arterial blood pressure (MAP) obtained in 3 rats dialyzed with 1 mM muscimol.

Dialysis with aCSF, 1 mM, and 10 mM muscimol: Effects on response to CO2. In the aCSF group (Fig. 2), neither the absolute values of CO2-stimulated VE, VT, and f nor the change in these values, comparing CO2- stimulated with the average of pre- and post-CO2 baseline values, differed significantly among the three dialysis tests.

In the 1 mM muscimol dialysis group (Fig. 3), absolute VE with CO2 stimulation was significantly decreased both during and after muscimol dialysis (one-way repeated-measures ANOVA; F = 22.87; df = 2; P < 0.001; P < 0.05, post hoc Dunnett's test). Mean ± SE values of absolute VE (expressed as ml · min-1 · 100 g-1) were 250 ± 15 before muscimol; 202 ± 22 during muscimol; and 202 ± 20 after muscimol. This represents an average decrease of -19%. The change in VE was also significantly decreased (F = 12.765; df = 2; P = 0.002; P < 0.05, post hoc Dunnett's test) both during and after muscimol from 171 ± 15 ml · min-1 · 100 g-1 to 133 ± 20 and 134 ± 17, respectively, an average decrease of -22%.

Absolute VT was decreased by 1 mM muscimol (F = 4.629; df = 2; P = 0.038) both during and after muscimol (P < 0.05, Dunnett's test) from 1.55 ± 0.02 ml/100 g to 1.41 ± 0.06 and 1.41 ± 0.05, respectively, an average decrease of -9%. However, the change in VT produced by the CO2 stimulus was not significantly different among the three measurement periods. The absolute f was significantly decreased (F = 10.241; df = 2; P = 0.004) both during and after (P < 0.05; Dunnett's test) 1 mM muscimol dialysis from 157 ± 10 min-1 to 141 ± 9 and 140 ± 9 min-1, respectively, an average decrease of -10%. The change in f produced by the CO2 stimulus was not significantly different among the three measurement periods.

In the 10 mM muscimol dialysis group (Fig. 4), absolute CO2-stimulated VE was not significantly affected, nor was the change in VE. Absolute VT was decreased by muscimol (one-way repeated-measures ANOVA; F = 4.528; df = 2; P = 0.048) and after muscimol (P < 0.05, Dunnett's test) from 1.52 ± 0.2 ml/100 g to 1.24 ± 0.06 ml/100 g, an average decrease of -18%. The change in VT produced by the CO2 stimulus was not significantly different among the three measurement periods. The absolute f was not significantly affected, nor was the change in f produced by the CO2 stimulus.

Anatomical location of dialysis probes. Figure 7 shows computer-modified, digitized ×2 images of cresyl violet-stained medullary cross sections at the approximate center of the tissue disruption at the site of the dialysis probe tip for animals that received the 1 mM muscimol. In each case, the probe tip was in the region of the RTN. The results (not shown) are similar for the other animals. The image at bottom right shows the cross section of the medulla taken from a separate rat that shows the greatest area of fluorescence after 30-min dialysis of fluorescein and 15 min of aCSF washout. In two such rats, the volume of tissue fluorescein distribution was 724 and 703 nl, respectively. The average rostral-to-caudal spread was 900 µm, and the average radius of the cross section with largest fluorescein area was 650 µm. Figure 8 shows three medullary cross sections from one rat taken at different rostral-caudal levels to show the path of the guide tube, which traverses the medulla in a plane different from that of the sections. At bottom right at higher magnification, the site of the probe tip is shown. Note gliosis and thickening of meninges.


View larger version (109K):
[in this window]
[in a new window]
  		Fig. 7.   Five computer-modified images of medullary cross sections show the center of the dialysis probe tip for the rats in the 1 mM muscimol dialysis group. Approximate distance from bregma is shown at lower left or right for each cross section. Scale bar is 1 mm. VII, facial nucleus. Results are similar for other rats in the study. Bottom right: cross section of the medulla taken from a separate rat, showing the greatest area of fluorescence after 30-min dialysis of fluorescein and 15 min of aCSF washout. In this example, chosen to demonstrate the spread of muscimol, the probe tip was slightly lateral to those that received 1 mM muscimol.



View larger version (81K):
[in this window]
[in a new window]
  		Fig. 8.   Medullary cross sections obtained from one rat at the levels of the rostral-caudal axis, shown by the numbers, which are referenced to the bregma. Note the darkened areas in A, B, and C showing disrupted areas caused by the guide tube and thus the pathway through the medulla of the guide tube, which traverses the medulla in a plane different from that of the sections. The damage at the tip (C) shows the location of the dialysis probe, which is in the region ventral to the facial nucleus, the RTN. D gives a higher power version of C.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Limitations of technique. Microdialysis is a useful technique to deliver neuroactive substances to a focal region of the medulla of the unanesthetized rat. We have used this approach successfully for thyrotropin-releasing hormone (TRH) and CO2 in the RTN region (7, 16). One concern about the technique is the degree of spread of the dialyzed substance within the tissue. For CO2, we measured tissue pH at different distances from the dialysis probe. For TRH and muscimol, it is more difficult to measure the exact tissue region affected. However, we can estimate this region by using data from the literature and from our own studies of the spread via dialysis of fluorescein, which has a molecular weight similar to muscimol and TRH.

From the literature, it appears that a considerable concentration difference of neuroactive substance is required between the inside and outside of the dialysis probe. Measures of tissue delivery of glutamate (2) dialyzed at 10-1,000 mM and 2.0 µl/min for 30 min showed a 35% delivery. For our 1 mM muscimol dialysis, this would result in a maximum concentration of 0.35 mM outside the probe. A drug dialysis study using two probes, one for delivery, the other for collection and measurement, showed a similar finding: steady-state concentrations 1.5 mm from the delivery probe that were 10-100 times lower than in the dialysate (8).

As reported in our initial dialysis paper (7), the use of our fluorescein marker with 1 mM concentration in the probe showed an average (n = 5) rostral-to-caudal spread of 870 µm and an average radius at the cross section with the largest area of 555 µm. The estimated volume of distribution was 590 nl, which is 49% of the approximate volume of the RTN region (1.2 µl). The results from similar dialysis of fluorescein in two additional rats in this study are similar: 713 nl, 900 µm rostral-to-caudal spread, and 650 µm average radius of cross section with largest area. From these data, we estimate that, with dialysis of 1 mM muscimol, the tissue distribution is likely to be predominantly within the RTN region and the concentration at the probe is likely to be 0.35 mM or less.

Dialysis with 10 mM muscimol most certainly affected a larger region. The average volume for dialysis with fluorescein at 10 mM was 1,580 nl (7), 2.7 times greater than with 1 mM. After 90 min in the 10-mM muscimol group, Tb decreased to values of 36°C and f and VE increased in temporal association with this hypothermia, suggesting that spread of the muscimol to adjacent regions may have occurred. In a single experiment, we dialyzed the lower 1 mM muscimol dose directly into the medullary raphe and observed a similar large fall in Tb, which, in this case, occurred immediately with the onset of dialysis. We hypothesize that the fall in Tb and the associated increase in f reflect events involving muscimol actions within the medullary raphe. We have chosen to limit our data presentation to the time period before this large drop in Tb.

Effects of muscimol dialysis in the RTN. The major findings in this study are that dialysis of muscimol at the 1 mM dose into the RTN region of the conscious rat decreases VT and VE reversibly without affecting VO2 and Tb, at least within the period of the dialysis and immediately thereafter. Dialysis of muscimol at the 10 mM dose also significantly decreases VT. The results are complicated by the observation that f increases within, and shortly after, the period of muscimol dialysis in both the 1 mM and 10 mM experiments, being larger and reaching statistical significance in the latter. The net effect on VE is complex, with an initial decrease that is predominantly the result of the strong muscimol effect on VT, followed by a return to baseline within minutes of cessation of muscimol dialysis, reflecting the delayed increase in f.

The response to CO2 is also altered in a similar manner, an effect most clearly seen in the 1 mM results. Both the absolute level of CO2-stimulated VE and the CO2-induced change in VE were significantly decreased by 19-22%, suggesting an effect on the central chemoreceptor system. Both VT and f were decreased in absolute values, although their change was not significantly affected. In the 10 mM results, the response of absolute VT was significantly reduced, but VE was unaffected because of the increase in f that occurred during the experiment.

We suggest that this increase in f represents two processes. First, there is an attempt by the animal to maintain normal VE in the presence of a powerful inhibition of VT with constant metabolic rate. The mechanism for this response is not known but could involve immediate responses at non-RTN chemoreceptor sites to increases in PCO2 associated with the initial hypoventilation. Second, the increase in f could reflect spread of muscimol into adjacent regions at which a nonchemoreceptor effect may arise. As mentioned above, in the 10 mM fluorescein experiments, there was a greater tissue volume affected, and, in the 10-mM muscimol experiments, delayed changes in Tb and f were observed.

We interpret our experiments to support the hypothesis that the RTN provides a tonic drive to respiratory control neurons, even in the awake unanesthetized state. In the conscious rat, this seems to predominantly affect VT. There is anatomical evidence for GABAA receptors in this region (29). And, in anesthetized animals, muscimol or GABA applied to the brain surfaces by cisternal injection or ventriculocisternal perfusion inhibits respiratory output (13, 27). Application directly to the VLM surface in anesthetized animals also decreases respiratory output and blood pressure (12, 14, 28). Direct injection of muscimol (200 nl; 5-10 mM) into the ventral medulla in anesthetized cats can decrease blood pressure without effects on breathing, indicating an anatomical specificity of sites for effects on breathing and blood pressure (11).

Comparison of RTN chemoreceptor stimulation and muscimol inhibition. Focal stimulation of the RTN region by microdialysis of CO2 in the awake rat increases VE by ~18% entirely as a result of an increase in VT. The stimulus intensity at the center of the focal region of acidosis was like that caused by inhalation of 9% CO2, and the region of acidosis was limited to within 550 µm of the probe in the anesthetized rat (16). In the present experiment, inhibition of RTN neurons in the awake rat by microdialysis of muscimol (1 mM) decreases the response to systemic hypercapnia by 19-22%. These separate results indicate that neurons in this region provide a portion of the CO2-related drive to breathe in the awake rat.

The presence of other chemoreceptor sites, both centrally (3, 6, 15-18, 20) and in the periphery, and the use of an animal model with a "closed-loop" control system complicate the quantitative analysis of these data. As noted above, inhibition of VE by muscimol without change in metabolic rate would increase CO2, which can stimulate non-RTN chemoreceptors. The final level would reflect a balance of muscimol-induced inhibition in the RTN region and CO2 excitation at other chemoreceptor locations. Similarly, stimulation of VE by focal CO2 dialysis in the RTN may lower CO2 levels at other chemoreceptor locations, again tempering the quantitative nature of the response. Thus the use of a conscious rat with a closed-loop control system to examine focal effects in the RTN may disguise the overall importance of neurons in the RTN region in the control of breathing. However, this type of experiment demonstrates the significance of having many central chemoreceptor locations; they can temper or modulate responses that might arise at a single location. Further, we can postulate that the large sensitivity of the respiratory control system to small changes in brain interstitial fluid pH, when studied in the unanesthetized state (9), requires that many chemoreceptor locations simultaneously stimulated. The presence of many chemoreceptor sites, each with moderate sensitivity, would provide stability in that no single site can easily bring about a large change in VE (this concept arises from discussions with John Remmers). When all sites are stimulated, high sensitivity occurs as a result of an additive, or multiplicative, interaction. Here, with inhibition of one site, the RTN, the system response quickly corrects the initial hypoventilation.

Effects of dialysis of TRH in the RTN: Comparison to muscimol. In a study similar to this one, we dialyzed TRH into the RTN of conscious rats (7). Both 1 mM and 10 mM doses produced an increase in VE, Tb, VO2, and arousal, but the effects were greater and longer lasting with the 10-mM dose. Our interpretation was that the RTN may be involved in the integration of signals, which can match changes in VE to changes in metabolic rate. The observed stimulation of breathing was appropriate for the observed increase in metabolism. For muscimol, the decrease in VE occurs without a change in metabolic rate, suggesting the presence of hypoventilation, a disruption of the link between VE and metabolism.

What is the quantitative importance of the RTN in the control of breathing? Why did bilateral coagulation of the RVLM (25) in cats and bilateral cooling of the RVLM in conscious goats (10) show greater effects on breathing both at rest and in response to hypercapnia than our lesion (1) and muscimol (this study) experiments? How can we compare responses to neurotoxin lesions of the RTN region in conscious rats with responses to reversible inhibition of the RTN by muscimol?

For the first issue, there are clear differences in approaches. Different species are involved, but, perhaps more importantly, the volume of tissue affected by bilateral coagulation (25) or cooling (10) is certainly much greater than in our unilateral lesion (1) and muscimol dialysis experiments. Destruction or cooling of more RTN neurons (including contiguous RVLM neurons) seems likely to have a greater effect on breathing and CO2 sensitivity.

For the second issue, the neurotoxin-induced lesions had no effect on resting breathing but decreased the response to 7% CO2 by 39% (1), whereas 1 mM muscimol dialysis decreased VE by 15-20% and the response to 7% CO2 by 19-22%. For the lesion experiments, we used cell counts to estimate that 35% of one RTN region was destroyed; for the muscimol dialysis we used fluorescein dialysis to estimate that up to 49% of the RTN was affected (7). The RTN tissue volumes affected by neurotoxin lesion and muscimol dialysis are similar. Why is the CO2 much more reduced in the lesion experiment and the resting VE reduced only in the muscimol dialysis experiment? The greatest difference in the two protocols is in the timing and reversibility of the RTN disruption. Muscimol has an effect in 5 min that is reversible within 60 min of cessation of dialysis. The lesions (1) were produced under anesthesia and are permanent, and their effects were not studied until 48 h after their production. It is possible that some type of neuronal plasticity or adaptation occurred in the 2 days of recovery allowed in that protocol. It is also possible that there were small differences in the anatomical nature of the neurons affected in the two studies, differences that we cannot, at present, detect with the anatomical techniques used.

Conclusions and physiological significance. We conclude that the RTN provides an important excitatory input to neurons that determine the VT and the overall level of VE in the awake resting state and that the RTN is involved in the response to systemic hypercapnia during wakefulness.


    ACKNOWLEDGEMENTS

Kate Creskoff, Nicole Eftichiou, Mary Mulcahey, and Cassandra Bevan helped perform these experiments.


    FOOTNOTES

This research was supported by National Heart, Lung, and Blood Institute Grant HL-28066.

Address for reprint requests and other correspondence: E. Nattie, Dept. of Physiology, Borwell Bldg., Dartmouth Medical School, Lebanon, NH 03756-0001 (E-mail: eugene.nattie{at}dartmouth.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Received 21 June 1999; accepted in final form 8 March 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Akilesh, MR, Kamper M, Li A, and Nattie EE. Effects of unilateral lesions of retrotrapezoid nucleus on breathing in awake rats. J Appl Physiol 82: 469-479, 1997[Abstract/Free Full Text].

2.   Alessandri, B, Landolt H, Langemann H, Gregorin J, Hall J, and Gratzl O. Application of glutamate in the cortex of rats: a microdialysis study. Acta Neurochir 67, Suppl: 6-12, 1996.

3.   Bernard, DG, Li A, and Nattie EE. Evidence for chemoreception in the medullary raphe. J Appl Physiol 80: 108-115, 1996[Abstract/Free Full Text].

4.   Bruce, EN, and Cherniack NS. Central chemoreceptors. J Appl Physiol 62: 389-402, 1987[Abstract/Free Full Text].

5.   Budzinska, K, von Euler C, Kao FF, Panteleo T, and Yamamoto Y. Effects of graded focal cold block in the rostral areas of the medulla. Acta Physiol Scand 124: 329-340, 1985[Medline].

6.   Coates, EL, Li A, and Nattie EE. Widespread sites of brainstem ventilatory chemoreceptors. J Appl Physiol 75: 5-14, 1993[Abstract/Free Full Text].

7.   Cream, CL, Nattie E, and Li A. TRH microdialysis into the RTN of the conscious rat increases breathing, metabolism, and temperature. J Appl Physiol 87: 673-682, 1999[Abstract/Free Full Text].

8.   De Lange, E, Bouw M, Mandema J, Danhof M, de Bour A, and Breimer D. Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain. Br J Pharmacol 116: 2538-2544, 1995[Web of Science][Medline].

9.   Fencl, V, Miller TB, and Pappenheimer JR. Studies on the respiratory response to disturbances of acid-base balance, with deductions concerning the ionic composition of cerebral interstitial fluid. Am J Physiol 210: 459-472, 1966.

10.   Forster, HV, Ohtake PJ, Pan LG, and Lowry TF. Effect on breathing of surface ventrolateral medullary cooling in awake, anesthetized and asleep goats. Respir Physiol 110: 187-197, 1997[Web of Science][Medline].

11.   Gatti, PJ, DaSilva AMT, and Gillis RA. Cardiorespiratory effects produced by injecting drugs that affect GABA receptors into nuclei associated with the ventral surface of the medulla. Neuropharmacology 26: 423-431, 1987[Web of Science][Medline].

12.   Haxhiu, MA, Mitra J, Van Lunteren E, Prabhakar N, Bruce EN, and Cherniack NS. Responses of hypoglossal and phrenic nerves to decreased respiratory drive in cats. Respiration 50: 130-138, 1986[Web of Science][Medline].

13.   Kneussl, MP, Pappagianopoulos P, Hoop B, and Kazemi H. Reversible depression of ventilation and cardiovascular function by ventriculocisternal perfusion with gamma-aminobutyric acid in dogs. Am Rev Respir Dis 133: 1024-1028, 1986[Web of Science][Medline].

14.   King, KA, and Holtman JR, Jr. Gamma-aminobutyric acid receptors at the ventral surface of the medulla inhibit respiratory motor outflow to the laryngeal musculature. Neuropharmacology 28: 255-263, 1989[Web of Science][Medline].

15.   Li, A, and Nattie EE. Focal central chemoreceptor sensitivity in the RTN studied with a CO2 diffusion pipette in vivo. J Appl Physiol 83: 420-428, 1997[Abstract/Free Full Text].

16.   Li, A, Randall M, and Nattie EE. CO2 microdialysis in the retrotrapezoid nucleus of the rat increases breathing in wakefulness but not in sleep. J Appl Physiol 87: 910-919, 1999[Abstract/Free Full Text].

17.   Nattie, EE. Central chemoreceptors, pH, and respiratory control. In: PH and Brain Function, edited by Kaila K, and Ransom BR.. New York: Wiley, 1998, p. 535-560.

18.   Nattie, EE. CO2, brainstem chemoreceptors, and breathing. Prog Neurobiol 59: 299-331, 1999[Web of Science][Medline].

19.   Nattie, EE, and Li A. Retrotrapezoid nucleus lesions decrease phrenic activity and CO2 sensitivity in rats. Respir Physiol 97: 63-77, 1994[Web of Science][Medline].

20.   Nattie, EE, and Li A. Central chemoreception in the region of the ventral respiratory group of the rat. J Appl Physiol 81: 1987-1995, 1996[Abstract/Free Full Text].

21.   Nattie, EE, Li A, and St John WM. Lesions in retrotrapezoid nucleus decrease ventilatory output in anesthetized or decerebrate cats. J Appl Physiol 71: 1364-1375, 1991[Abstract/Free Full Text].

22.   Ohtake, PJ, Forster HV, Pan LG, Lowry TF, Korducki MJ, Aaron EA, and Weiss EM. Ventilatory responses to cooling the ventrolateral medullary surface of awake and anesthetized goats. J Appl Physiol 78: 247-257, 1995[Abstract/Free Full Text].

23.   Pappenheimer, JR. Sleep and respiration of rats during hypoxia. J Physiol (Lond) 266: 191-207, 1977[Abstract/Free Full Text].

24.   Paxinos, G, and Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic, 1986.

25.   Schlöfke, ME. Elimination of central chemosensitivity by coagulation of a bilateral area on the ventral medullary surface in awake cats. Pflügers Arch 379: 231-241, 1979.

26.   Smith, JC, Morrison DE, Ellenberger HH, Otto MR, and Feldman J. Brainstem projections to the major respiratory neuron populations in the medulla of the cat. J Comp Neurol 281: 69-96, 1989[Web of Science][Medline].

27.   Yamada, KA, Hamosh P, and Gillis R. Respiratory depression produced by activation of GABA receptors in hindbrain of cat. J Appl Physiol 51: 1278-1286, 1981[Abstract/Free Full Text].

28.   Yamada, KA, Norman WP, Hamosh P, and Gillis R. Medullary ventral surface GABA receptors affect respiratory and cardiovascular function. Brain Res 248: 71-78, 1982[Web of Science][Medline].

29.   Xia, Y, and Haddad GG. Ontogeny and distribution of GABAA receptors in rat brainstem and rostral brain regions. Neuroscience 49: 973-989, 1992[Web of Science][Medline].

J APPL PHYSIOL 89(1):153-162
8570-7587/00 $5.00 Copyright © 2000 the American Physiological Society


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
E. Nattie and A. Li
Central chemoreception is a complex system function that involves multiple brain stem sites
J Appl Physiol, April 1, 2009; 106(4): 1464 - 1466.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
P. G. Guyenet
The 2008 Carl Ludwig Lecture: retrotrapezoid nucleus, CO2 homeostasis, and breathing automaticity
J Appl Physiol, August 1, 2008; 105(2): 404 - 416.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. C. Takakura, T. S. Moreira, R. L. Stornetta, G. H. West, J. M. Gwilt, and P. G. Guyenet
Selective lesion of retrotrapezoid Phox2b-expressing neurons raises the apnoeic threshold in rats
J. Physiol., June 15, 2008; 586(12): 2975 - 2991.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. G. Fortuna, G. H. West, R. L. Stornetta, and P. G. Guyenet
Botzinger Expiratory-Augmenting Neurons and the Parafacial Respiratory Group
J. Neurosci., March 5, 2008; 28(10): 2506 - 2515.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
T. S. Moreira, A. C. Takakura, E. Colombari, and P. G. Guyenet
Activation of 5-Hydroxytryptamine Type 3 Receptor-Expressing C-Fiber Vagal Afferents Inhibits Retrotrapezoid Nucleus Chemoreceptors in Rats
J Neurophysiol, December 1, 2007; 98(6): 3627 - 3637.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
A. C. Takakura, T. S. Moreira, G. H. West, J. M. Gwilt, E. Colombari, R. L. Stornetta, and P. G. Guyenet
GABAergic Pump Cells of Solitary Tract Nucleus Innervate Retrotrapezoid Nucleus Chemoreceptors
J Neurophysiol, July 1, 2007; 98(1): 374 - 381.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
T. S. Moreira, A. C. Takakura, E. Colombari, G. H. West, and P. G. Guyenet
Inhibitory input from slowly adapting lung stretch receptors to retrotrapezoid nucleus chemoreceptors
J. Physiol., April 1, 2007; 580(1): 285 - 300.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. Li, S. Zhou, and E. Nattie
Simultaneous inhibition of caudal medullary raphe and retrotrapezoid nucleus decreases breathing and the CO2 response in conscious rats
J. Physiol., November 15, 2006; 577(1): 307 - 318.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. C. T. Takakura, T. S. Moreira, E. Colombari, G. H. West, R. L. Stornetta, and P. G. Guyenet
Peripheral chemoreceptor inputs to retrotrapezoid nucleus (RTN) CO2-sensitive neurons in rats
J. Physiol., April 15, 2006; 572(2): 503 - 523.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. G. Guyenet, D. K. Mulkey, R. L. Stornetta, and D. A. Bayliss
Regulation of Ventral Surface Chemoreceptors by the Central Respiratory Pattern Generator
J. Neurosci., September 28, 2005; 25(39): 8938 - 8947.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. W. Putnam, J. A. Filosa, and N. A. Ritucci
Cellular mechanisms involved in CO2 and acid signaling in chemosensitive neurons
Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1493 - C1526.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
E. E. Nattie, A. Li, G. Richerson, and D. A. Lappi
Medullary serotonergic neurones and adjacent neurones that express neurokinin-1 receptors are both involved in chemoreception in vivo
J. Physiol., April 1, 2004; 556(1): 235 - 253.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Z. Chen and J. B. Travers
Inactivation of amino acid receptors in medullary reticular formation modulates and suppresses ingestion and rejection responses in the awake rat
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R68 - R83.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. L Morrison, S. Sood, H. Liu, E. Park, P. Nolan, and R. L Horner
GABAA receptor antagonism at the hypoglossal motor nucleus increases genioglossus muscle activity in NREM but not REM sleep
J. Physiol., April 15, 2003; 548(2): 569 - 583.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. L. Morrison, S. Sood, X. Liu, H. Liu, E. Park, P. Nolan, and R. L. Horner
Glycine at hypoglossal motor nucleus: genioglossus activity, CO2 responses, and the additive effects of GABA
J Appl Physiol, November 1, 2002; 93(5): 1786 - 1796.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
E. E Nattie and A. Li
Substance P-saporin lesion of neurons with NK1 receptors in one chemoreceptor site in rats decreases ventilation and chemosensitivity
J. Physiol., October 15, 2002; 544(2): 603 - 616.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. Jelev, S. Sood, H. Liu, P. Nolan, and R. L Horner
Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats
J. Physiol., April 15, 2001; 532(2): 467 - 481.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nattie, E.
Right arrow Articles by Li, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nattie, E.
Right arrow Articles by Li, A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online